Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Tagworks Pharmaceuticals is a privately held biotech company
RxLightning automates the manual enrollment process of starting a patient on specialty medications.
Amphista Therapeutics operates as a biopharmaceutical company.
Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.
Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Transforming medical data into predictive algorithms without code
NuvoAir is a value-based specialty management platform transforming the diagnosis and management of chronic heart and lung conditions.
SiO2 Materials Science is a plastic container designing company.
Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Soteria is a biotechnology company that develops immunotherapies to treat cancer patients
Ayala Pharmaceuticals a clinical-stage biopharmaceutical company focused on developing and commercializing small molecule therapeutics.
Aspen RxHealth is a service powered by an app-based platform that connects pharmacists with patients.
AccessNow is a platform that serves as a go-to resource for accessibility information.
Arctos Medical is a developed gene therapy that does not correct rare genetic eye diseases but much more common cases of blindness.
DescriptionIFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Novartis has invested in 101 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novartis's top investment sectors include Biotechnology, Health Care, Therapeutics, Biopharma, Medical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Anthos Therapeutics received $250.0M in a Series A round. Novartis's total known invested capital is $2.8B.
Novartis's average investment size is $54.3M across its portfolio of 101 companies.
Recent Novartis portfolio additions include Hyku, Poseida Therapeutics, Tagworks Pharmaceuticals, RxLightning, Amphista Therapeutics. These companies were founded in 2020 or later.